BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9179349)

  • 1. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Jun; 54(11):1287-92. PubMed ID: 9179349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of doripenem with other drugs during simulated Y-site administration.
    Brammer MK; Chan P; Heatherly K; Trusley C; Kupiec TC; Trissel LA; Psathas PA; Gilmor T; Schaufelberger D
    Am J Health Syst Pharm; 2008 Jul; 65(13):1261-5. PubMed ID: 18574017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Simmons M
    J Am Pharm Assoc (Wash); 1999; 39(2):141-5. PubMed ID: 10079649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
    Chan P; Bishop A; Kupiec TC; Trissel LA; Gole D; Jimidar IM; Vermeersch H
    Am J Health Syst Pharm; 2008 Aug; 65(16):1545-51. PubMed ID: 18693210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incompatibility of propofol emulsion with anesthetic drugs.
    Lamontagne C; Brouillette D; Hardy JF
    Anesthesiology; 1998 Dec; 89(6):1609. PubMed ID: 9856757
    [No Abstract]   [Full Text] [Related]  

  • 10. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Jul; 51(14):1792-9. PubMed ID: 7942908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1996 May; 53(9):1041-5. PubMed ID: 8744467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
    Trissel LA; Saenz CA; Ogundele AB; Ingram DS
    Am J Health Syst Pharm; 2004 Nov; 61(21):2289-93. PubMed ID: 15552637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Dec; 54(23):2708-13. PubMed ID: 9408515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and Chemical Compatibility of Etomidate and Propofol Injectable Emulsions.
    Wang C; Wang S; Wu C; Lei L; Wang DX; Zhang Q
    Pharmacology; 2021; 106(11-12):644-657. PubMed ID: 34644710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of aztreonam with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 May; 52(10):1086-90. PubMed ID: 7656099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol compatibility with other intravenous drug products: two new methods of evaluating IV emulsion compatibility.
    Michaels MR; Stauffer GL; Haas DP
    Ann Pharmacother; 1996 Mar; 30(3):228-32. PubMed ID: 8833555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.
    Nemec K; Germ E; Schulz-Siegmund M; Ortner A
    Pharmazie; 2009 Feb; 64(2):94-7. PubMed ID: 19320281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and compatibility of granisetron hydrochloride in i.v. solutions and oral liquids and during simulated Y-site injection with selected drugs.
    Mayron D; Gennaro AR
    Am J Health Syst Pharm; 1996 Feb; 53(3):294-304. PubMed ID: 8808027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of amifostine with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 Oct; 52(20):2208-12. PubMed ID: 8564592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.
    Thabit AK; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2017 Jan; 74(1):e47-e54. PubMed ID: 28007721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.